Exercise capacity study of LCZ696 vs. enalapril in patients with chronic heart failure and reduced ejection fraction

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-004632-35

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to demonstrate the superiority of LCZ696 200 mg bid compared to enalapril 10 mg bid in improving exercise tolerance (VO2peak, adjusted to lean body weight) as assessed by cardiopulmonary exercise testing (CPET) in patients with stable chronic heart failure (NYHA class III) and reduced ejection fraction (LVEF ≤ 40%) after 3 months treatment.


Critère d'inclusion

  • chronic heart failure and reduced ejection fraction

Liens